Regulation of the slowly activating component of delayed rectifier K ؉ current (I Ks ) by membrane phospholipid phosphatidylinositol 4,5-bisphosphate (PtdIns-(4,5)P 2 ) was examined in guinea pig atrial myocytes using the whole-cell patch clamp method. I Ks was elicited by depolarizing voltage steps given from a holding potential of ؊50 mV, and the effect of various test reagents on I Ks was assessed by measuring the amplitude of tail current elicited upon return to the holding potential following a 2-s depolarization to ؉30 mV. Intracellular application of 50 M wortmannin through a recording pipette evoked a progressive increase in I Ks over a 10 -15-min period to 208.5 ؎ 14.6% (n ؍ 9) of initial magnitude obtained shortly after rupture of the patch membrane. Intracellular application of anti-PtdIns(4,5)P 2 monoclonal antibody also increased the amplitude of I Ks to 198.4 ؎ 19.9% (n ؍ 5). In contrast, intracellular loading with exogenous PtdIns(4,5)P 2 at 10 and 100 M produced a marked decrease in the amplitude of I Ks to 54.3 ؎ 3.8% (n ؍ 5) and 44.8 ؎ 8.2% (n ؍ 5), respectively. Intracellular application of neomycin (50 M) or aluminum (50 M) evoked an increase in the amplitude of I Ks to 161.0 ؎ 13.5% (n ؍ 4) and 150.0 ؎ 8.2% (n ؍ 4), respectively. These results strongly suggest that I Ks channel is inhibited by endogenous membrane PtdIns(4,5)P 2 through the electrostatic interaction with the negatively charged head group on PtdIns(4,5)P 2 . Potentiation of I Ks by P2Y receptor stimulation with 50 M ATP was almost totally abolished when PtdIns(4,5)P 2 was included in the pipette solution, suggesting that depletion of membrane PtdIns(4,5)P 2 is involved in the potentiation of I Ks by P2Y receptor stimulation. Thus, membrane PtdIns(4,5)P 2 may act as an important physiological regulator of I Ks in guinea pig atrial myocytes.The delayed rectifier K ϩ current (I K ) 1 is activated by membrane depolarization and thereby provides an outward current, which is essential for initiating phase 3 repolarization of the action potential in cardiac muscle. Two kinetically and pharmacologically distinct components of I K , I Kr (rapid) and I Ks (slow), have been identified in cardiac myocytes from various mammalian species (1, 2) including humans (3). The KCNQ1 gene encodes the pore-forming ␣ subunit, K V LQT1, that assembles with an accessory  subunit minK (I sK ) protein (encoded by KCNE1 gene) to produce the I Ks channel (4, 5), whereas the HERG (human ether-á -go-go-related gene) product forms the pore-forming subunit of the I Kr channel (6, 7). Mutations in any of these genes have been linked to long QT syndrome, an inherited cardiac arrhythmia characterized by abnormal ventricular repolarization and a high risk for sudden cardiac death (8).Previous studies have demonstrated that both I Ks and I Kr represent relevant targets for the actions of autonomic neurotransmitters, hormones, intracellular messengers, and exogenous drugs. I Ks is modulated by protein kinase A, protein kinase C (PKC), and intracellular ...